Interpheron action on leukocyte fagocitable capacity - in vitro
PDF (Македонски)



How to Cite

Угрински (Ugrinski), Предраг (Predrag), & Младеновиќ (Mladenovikj), Драгослав (Dragoslav). (2016). Interpheron action on leukocyte fagocitable capacity - in vitro. Medicinska Misla, 27(1), 3–5. Retrieved from


In atempt to get elementary insight of interpheron action on leukocyte fagocytable capacity, in vitro were tested fagocytes from the patients with various diseases. 

The fagocytable material was carbo animalis, interpheron was put in the medium and the percentage of fagocytosis was checked in every sample which consisted from 100 cells.

The results pointed out that interferon doesn't influence essentially on the fagocytable activity on the polymorphonuclears, while monocyte fagocytosis was increased about 20 percents.

PDF (Македонски)


Dawid R. Ј.: "¢ Federation Proc. 30 ; 1730, 1971

Snyderman R. Ð…. : Proc. Ѕоѕ. Ехр. Biol. and Med. 138 "¢387, 1971

Stewart Е. W.: Varied Biological Effect of lnterferon. Academic Press 1979

Ugrinski Ð . and al.: Ðm. Ј . of Path. 74 : 365. 1974

Ugrinski Ð . i sorabotnici. Godishen zbornik na Med fak . vol. XX II1 17-29, 1977.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

The Medicinska Misla applies the Creative Commons Attribution License (CCAL) to all works we publish (read the human-readable summary or the full license legal code). Under the CCAL, authors retain ownership of the copyright for their article, but authors allow anyone to download, reuse, reprint, modify, distribute, and/or copy articles in Medicinska Misla journal, so long as the original authors and source are cited. No permission is required from the authors or the publishers.

Creative Commons License

In most cases, appropriate attribution can be provided by simply citing the original article (e.g. Gogusev J, Chretien Y, Droz D. Aberrant Expression of Polycystin-1 in Renal Cell Tumors. Maced J Med Sci. 2008;1(1):11-16. doi:10.3889/MJMS.1857-5773.2008.0004). If the item you plan to reuse is not part of a published article (e.g. a featured issue image), then please indicate the originator of the work, and the volume, issue and date of the journal in which the item appeared. For any reuse or redistribution of a work, you must also make clear the license terms under which the work was published.

This broad license was developed to facilitate open access to, and free use of, original works of all types. Applying this standard license to your own work will ensure your right to make your work freely and openly available. Learn more about open access. For queries about the license, please contact us.


Download data is not yet available.